BSE List Price : ₹48.00

NSE List Price : ₹48.25

subscription

Category	Times
QIBs	19.77x
HNIs	161.49x
Retail	26.85x
Total : 53.68x

IPO Market Lot(s) Distribution

Application	Lot Size	Shares	Amount
Retail Minimum	1	333	₹14,985
Retail Maximum	13	4	₹194,805
S-HNI Minimum	14	329	₹209,790
S-HNI Maximum	66	4	₹989,010
B-HNI Minimum	67	662	₹1,003,995

About the Company

Established in 1993, Hexagon Nutrition Limited is among the prominent nutrition-focused companies in India. The company is engaged in the development and manufacturing of products across three key verticals: Micronutrient Premix Products, Clinical Nutrition, and Therapeutic Foods. It operates three manufacturing plants in India located at Nashik, Chennai, and Thoothukudi, along with an overseas facility in Tashkent, Uzbekistan.

The company’s product offerings are broadly classified into three categories:

Branded wellness and clinical nutrition products catering to the B2C segment
Premix formulations designed for the B2B2C market
Ready-to-Use Foods (RUFs) and Micronutrient Powders (MNPs) developed under ESG-focused initiatives

Hexagon Nutrition Limited distributes its products through various channels including retail pharmacies and medical stores, hospitals, e-commerce platforms, online medicine portals, and its own brands/websites such as Pentasure, Obesigo, Pediagold, and Nutrone. The company has a network of 342 distributors across India and has exported its products to over 75 countries spanning Asia, Africa, Europe, and South America.

Company Financial Report

_{Amount ₹ in Crores}

Period Ended	Revenue	Expense	PAT	Assets
2023	₹281.65	₹267.02	₹5.82	₹288.90
2024	₹304.62	₹285.48	₹12.21	₹250.54
2025	₹331.29	₹296.78	₹24.38	₹261.36
Dec 2025	₹275.57	₹239.83	₹27.03	₹327.60

Company Promoter

Arun Purushottam Kelkar

Subhash Purushottam Kelkar

Vikram Arun Kelkar

Nikhil Arun Kelkar

Know before investing

• • Strengths

  Comprehensive Nutrition Offerings: The company provides integrated nutrition solutions across the entire value chain, covering micronutrient premixes, therapeutic foods, and clinical nutrition products. Its broad and diversified product portfolio allows it to cater to B2B, B2C, as well as public health nutrition needs.

  Strong Research & Development Capabilities: The company has two in-house R&D facilities supported by a specialised team working on formulation development, ingredient compatibility, and sensory analysis. Its research capabilities support the creation of nutrition products while maintaining taste, texture, aroma, and nutritional value.

• • Risks

  Facility Redevelopment Risk: Ongoing reconstruction work at the Nashik manufacturing facility after earlier regulatory actions may lead to temporary interruptions in production, operational challenges, and possible impact on revenue generation.

  Quality and Regulatory Compliance Risk: Any distribution of expired, substandard, or non-compliant nutrition products, or inability to adhere to prescribed quality standards, may result in legal actions, reputational harm, and negative effects on business operations.

Objects of the Issue & Utilisation of proceeds

NA

Company  Address

Hexagon Nutrition Ltd.
404 Global Chamber
Adarsh Nagar Link Road
Andheri (W)
Mumbai, Maharashtra, 400053
Phone: +91 22 6213 6710
Email: cs.hnpl@hexagonnutrition.com
Website: https://hexagonnutrition.com/

IPO Registrar

Kfin Technologies Ltd.
Phone: 04067162222, 04079611000
Email: hexagon.ipo@kfintech.com
Website: https://ipostatus.kfintech.com/

IPO Review

May Apply